GENEVA, Oct. 13 -- AC IMMUNE SA (EPFL Innovation Park, Building B1015 Lausanne) filed a patent application (PCT/EP2025/058993) for "NOVEL COMPOUNDS FOR THE DIAGNOSIS OF TDP-43 PROTEINOPATHIES" on Apr 02, 2025. With publication no. WO/2025/210087, the details related to the patent application was published on Oct 09, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): DREYFUS, Nicolas (EPFL Innovation Park, Building B1015 Lausanne)
Abstract: The present invention relates to compounds which are suitable for imaging TDP-43 (Transactive response (TAR) DNA binding protein 43 kDa) aggregates. The com...